In June, a bidding war for Spectris began with an initial offer from Advent. After KKR entered the fray with its own bid, the British company's board repeatedly changed its recommendation between the ...

Spectris has failed to achieve such ratings as a public company due to weaker profitability, low scale and relative ...

In July 2025, there were five Rule 2.7 announcements made across the UK public M&A market and three further possible offers ...

Spectris raised its interim dividend by 5.3% to 28 pence per share from 26.6p. Spectris on Tuesday withdrew its recommendation of a takeover offer from Advent International LP and instead backed an ...

A smart beta exchange traded fund, the Schwab Fundamental International Small Company Index ETF (FNDC) debuted on 08/13/2013, and offers broad exposure to the Foreign Small/Mid Value ETF category of ...

Precision instrumentation supplier Spectris said on Thursday that second-quarter momentum and strategic cost savings had ...

Investing.com -- Spectris (LON: SXS) plc, the precision measurement specialist, on Thursday reported an 8% increase in first-half sales and maintained its full-year profit guidance despite mixed ...

KKR has upped its offer for British scientific instruments maker Spectris to £4.8bn, regaining backing from the company over ...

Index Ventures was among the first investors in startup hits Figma, Scale AI and Wiz. Fast-moving quantitative funds are meant to flourish in tough markets but, with President Trump's tariff moves ...

KKR Lifts Spectris Offer to $5.6 Billion Amid Bidding War With Advent The sweetened offer comes days after Advent improved its bid for Spectris, prompting the target to withdraw its recommendation for ...

On Friday last week, Spectris had accepted the increased offer from Advent and withdrew its recommendation of a GBP40 per share bid from KKR but switched horses again on Tuesday. The acquisition is ...

KKR ups its bid for Spectris to £4.2 billion, overtaking Advent in a fierce takeover race for the UK scientific instruments ...